KCNA3 and cancer: Studies performed recently on the channels expressed in cancer cells—human Jurkat T cell line—provide evidence that naringenin was not an inhibitor of Kv1.3 channels in these cells when applied at concentrations up to 30 μM (Gąsiorowska—unpublished results).